Seven Eight Capital’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-36,978
| Closed | -$4.01M | – | 984 |
|
|
2024
Q2 | $4.01M | Buy |
36,978
+34,739
| +1,552% | +$4.1M | 0.42% | 39 |
|
|
2024
Q1 | $296K | Buy |
+2,239
| New | +$280K | 0.03% | 535 |
|
|
2022
Q4 | – | Sell |
-5,732
| Closed | -$599K | – | 662 |
|
|
2022
Q3 | $599K | Buy |
5,732
+3,226
| +129% | +$354K | 0.12% | 239 |
|
|
2022
Q2 | $263K | Sell |
2,506
-2,537
| -50% | -$301K | 0.11% | 280 |
|
|
2022
Q1 | $645K | Buy |
5,043
+2,838
| +129% | +$342K | 0.09% | 275 |
|
|
2021
Q4 | $272K | Sell |
2,205
-4,844
| -69% | -$634K | 0.05% | 372 |
|
|
2021
Q3 | $1M | Buy |
+7,049
| New | +$1.04M | 0.1% | 304 |
|
|
2020
Q4 | – | Sell |
-2,575
| Closed | -$340K | – | 658 |
|
|
2020
Q3 | $340K | Sell |
2,575
-9,476
| -79% | -$1.24M | 0.07% | 426 |
|
|
2020
Q2 | $1.4M | Buy |
+12,051
| New | +$1.39M | 1.02% | 8 |
|
|
2019
Q4 | – | Sell |
-26,521
| Closed | -$3.54M | – | 791 |
|
|
2019
Q3 | $3.54M | Sell |
26,521
-38,728
| -59% | -$5M | 0.19% | 160 |
|
|
2019
Q2 | $7.46M | Sell |
65,249
-618
| -0.9% | -$72.4K | 0.39% | 68 |
|
|
2019
Q1 | $8.17M | Buy |
+65,867
| New | +$7.49M | 0.43% | 60 |
|
|
2018
Q1 | – | Sell |
-11,277
| Closed | -$1.32M | – | 558 |
|
|
2017
Q4 | $1.32M | Sell |
11,277
-14,111
| -56% | -$1.6M | 0.13% | 231 |
|
|
2017
Q3 | $2.89M | Buy |
25,388
+21,321
| +524% | +$2.46M | 0.35% | 95 |
|
|
2017
Q2 | $507K | Sell |
4,067
-3,708
| -48% | -$440K | 0.07% | 306 |
|
|
2017
Q1 | $922K | Buy |
7,775
+6,798
| +696% | +$770K | 0.18% | 188 |
|
|
2016
Q4 | $98K | Buy |
+977
| New | +$105K | 0.02% | 460 |
|
|
2016
Q3 | – | Sell |
-50
| Closed | -$6K | – | 578 |
|
|
2016
Q2 | $6K | Buy |
+50
| New | +$5.66K | ﹤0.01% | 500 |
|
|
2015
Q4 | – | Sell |
-50
| Closed | -$5K | – | 709 |
|
|
2015
Q3 | $5K | Sell |
50
-4,944
| -99% | -$496K | ﹤0.01% | 482 |
|
|
2015
Q2 | $530K | Buy |
+4,994
| New | +$553K | 0.63% | 30 |
|
|
2014
Q4 | – | Sell |
-3,914
| Closed | -$382K | – | 682 |
|
|
2014
Q3 | $382K | Buy |
+3,914
| New | +$385K | 0.29% | 108 |
|
|
2014
Q2 | – | Sell |
-11,639
| Closed | -$1.07M | – | 604 |
|
|
2014
Q1 | $1.07M | Buy |
+11,639
| New | +$1.07M | 0.92% | 12 |
|
Other funds holding ZBH
Seven Eight Capital's ZBH Position: Q3 2024 in Review
Seven Eight Capital sold out of Zimmer Biomet (ZBH) in Q3 2024, closing a stake of 36,978 shares — an estimated $4.01M sold.
Seven Eight Capital first reported a position in ZBH in Q1 2014 and held it in 22 quarters. The position peaked at $8.17M in Q1 2019. 982 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.
- Seven Eight Capital reported no remaining Zimmer Biomet position as of Q3 2024 after selling out during the quarter.
- Seven Eight Capital sold 36,978 Zimmer Biomet shares in Q3 2024, an estimated $4.01M.
- Seven Eight Capital first reported a position in Zimmer Biomet in Q1 2014 and held it in 22 quarters.
- Seven Eight Capital's Zimmer Biomet position peaked at $8.17M in Q1 2019.
- 982 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.
Based on Seven Eight Capital's 13F filing for Q3 2024, filed 12 Nov 2024.